Print Page | Close Window

Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

November 24, 2015 - 5:01 p.m.
Gilead Sciences to Present at Two Upcoming Investor Conferences on Tuesday, December 1Printer Friendly Version 
November 23, 2015 - 6:36 a.m.
European Commission Grants Marketing Authorization for Gilead’s Single Tablet Regimen Genvoya® (Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide) for the Treatment of HIV-1 InfectionPrinter Friendly Version 

Upcoming Events

Tuesday, December 1, 2015
33rd NASDAQ OMX Investor Program
LocationLondon, UK
Tuesday, December 1, 2015
Piper Jaffray 27th Annual Healthcare Conference
LocationNew York, NY
Saturday, December 5, 2015 through Tuesday, December 8, 2015
57th American Society of Hematology (ASH) Annual Meeting and Exposition
LocationOrlando, FL

Most Viewed Links

Updated 11/25/15
1.SEC Filings
3.Annual Reports
4.Stock Information
5.Fundamentals - Snapshot
* Data collected 11/17/15 - 11/24/15

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.